forecasted

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Opportunity Number: PAR-26-064CFDA Numbers: 93.395
Posted: Closed on Sep 9, 2025

Stay Updated

Get notified about new opportunities matching your interests.